Krystexxa 8 MG/ML vialml
Ended Awarded
- Contract number
- SPE2DB25FL0H0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $111,807
Award facts
- Contract value 100% obligated
- $111,806.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $111,806.64 contract provides the DLA with Krystexxa 8 mg/ml vials, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.
The contract is not associated with a set-aside designation, which allows DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This IDC positions DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FL0H0?
SPE2DB25FL0H0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 22, 2024.
How much is contract SPE2DB25FL0H0 worth?
The government has obligated $111,807 on SPE2DB25FL0H0.
Is contract SPE2DB25FL0H0 an order under another contract?
Yes. SPE2DB25FL0H0 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB25FL0H0 competed?
The extent of competition for SPE2DB25FL0H0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award